Subscribe to Newsletter
Discovery & Development Analytical Science

Biopharmaceutical characterization demands advanced detection capabilities

Innovation that takes technology design to the physical limits

Discovery & Development Analytical Science

Biotherapeutic Protein Characterization Challenges: The NIBRT Perspective

NIBRT Principle Investigator Jonathan Bones discusses the challenges involved in biotherapeutic protein characterization.

Discovery & Development Analytical Science

Biopharmaceuticals are complex; analyzing them just got a lot easier

Great technology takes complex challenges and provides simple, robust solutions.

Manufacture Formulation

Solubilization challenges need new ways of bringing chemistry and engineering knowledge together

Hot Melt Extrusion helps to enable pharmaceutical companies to literally solve their solubilization issue.

Manufacture Packaging

Glass delamination brought under control

Dr. Bernhard Hladik from SCHOTT breaks down the delamination phenomenon and describes how pharma manufacturers can effectively fight back.

Business & Regulation Business Practice

Welcome to The Power List 2016

Welcome to The Power List 2016

Discovery & Development Drug Delivery

Around the World in 80 Microbes

| William Aryitey

Drug discovery doesn’t always begin in the lab…

Discovery & Development Formulation

Controlling Crystallization

Researchers working to gain greater knowledge into crystallization believe that functionalized glass can trigger nucleation of specific crystals.

Discovery & Development Packaging

Beyond Keeping Up Appearances

| Charlotte Miller

You have the perfect drug and the right packaging to protect it. All is well until the medication reaches the patient, who habitually pops the tablets into another container for easy storage or leaves them exposed to the atmosphere. Film coatings are more than just a pretty face.

Business & Regulation Business Practice

Making Small Biotech Work

| Bruno Speder

Innovation is increasingly coming from small biotechs, but such companies rely on external funding to develop the compounds. A solid regulatory strategy is essential to convince investors to fund the further development.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register